<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: paradigm shift</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests</title>
   	 <description>An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-02-antibody-hinders-growth-gleevec-resistant-gastrointestinal.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Feb 2013 15:00:08 EST</pubDate>
	 <guid isPermaLink="false">news279195778</guid>
	 
</item>
<item>
     <title>Tuberculosis's genetic 'family tree' may hold the key to tackling outbreaks quickly and effectively</title>
   	 <description>Researchers, led by the NIHR Oxford Biomedical Research Centre, the Health Protection Agency in Birmingham and the Wellcome Trust Sanger Institute in Cambridge, have pioneered the whole genome sequencing (WGS) method through a study of 254 TB cases in the Midlands.</description>
     <link>http://medicalxpress.com/news/2012-11-tuberculosis-genetic-family-tree-key.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 14 Nov 2012 18:30:05 EST</pubDate>
	 <guid isPermaLink="false">news272129666</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-tuberculosis.jpg" width="90" height="90" />
</item>
<item>
     <title>New genetic links for inflammatory bowel disease uncovered</title>
   	 <description>Crohn's disease (CD) and ulcerative colitis (UC) – inflammatory diseases of the gastrointestinal tract – have puzzled the scientific community for decades. Ten years ago, researchers recognized that both genes and the environment contributed to these diseases but knew little about precisely how and why illness occurred. To begin to narrow in on the key pathways involved, they would need thousands of patients' samples, millions of data points, and the commitment of physicians and scientists at dozens of institutions.</description>
     <link>http://medicalxpress.com/news/2012-10-genetic-links-inflammatory-bowel-disease.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 31 Oct 2012 15:11:57 EST</pubDate>
	 <guid isPermaLink="false">news270914505</guid>
	 
</item>
<item>
     <title>Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus</title>
   	 <description>Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London , discovered for the first time that children and young patients with chronic Hepatitis B Virus infection (HBV carriers) do have a protective immune response, contrary to current belief, and hence can be more suitable treatment candidates than previously considered.</description>
     <link>http://medicalxpress.com/news/2012-09-earlier-treatment-young-patients-chronic.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 06 Sep 2012 11:19:52 EST</pubDate>
	 <guid isPermaLink="false">news266149183</guid>
	 
</item>
<item>
     <title>ENCODE project: Researchers unlock disease information hidden in genome's control circuitry</title>
   	 <description>Researchers at the University of Washington have determined that the majority of genetic changes associated with more than 400 common diseases and clinical traits affect the genome's regulatory circuitry. These are the regions of DNA that contain instructions dictating when and where genes are switched on or off. Most of these changes affect circuits that are active during early human development, when body tissues are most vulnerable.</description>
     <link>http://medicalxpress.com/news/2012-09-encode-disease-hidden-genome-circuitry.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 05 Sep 2012 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news266059353</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/20-researchersu.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers discover new non-invasive method for diagnosing epilepsy</title>
   	 <description>(Medical Xpress)—A team of University of Minnesota biomedical engineers and researchers from Mayo Clinic published a groundbreaking study today that outlines how a new type of non-invasive brain scan taken immediately after a seizure gives additional insight into possible causes and treatments for epilepsy patients. The new findings could specifically benefit millions of people who are unable to control their epilepsy with medication.</description>
     <link>http://medicalxpress.com/news/2012-08-university-minnesota-non-invasive-method-epilepsy.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 24 Aug 2012 12:32:18 EST</pubDate>
	 <guid isPermaLink="false">news265030314</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/17-universityof.jpg" width="90" height="90" />
</item>
<item>
     <title>Small molecule may play big role in Alzheimer's disease</title>
   	 <description>Alzheimer's disease is one of the most dreaded and debilitating illnesses one can develop. Currently, the disease afflicts 6.5 million Americans and the Alzheimer's Association projects it to increase to between 11 and 16 million, or 1 in 85 people, by 2050.</description>
     <link>http://medicalxpress.com/news/2012-07-small-molecule-big-role-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 09 Jul 2012 17:39:50 EST</pubDate>
	 <guid isPermaLink="false">news261074372</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-smallmolecul.jpg" width="90" height="90" />
</item>
<item>
     <title>Discovery helps mice beat urinary tract infections</title>
   	 <description>Scientists at Washington University School of Medicine in St. Louis have found new clues to why some urinary tract infections recur persistently after multiple rounds of treatment.</description>
     <link>http://medicalxpress.com/news/2012-06-discovery-mice-urinary-tract-infections.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 18 Jun 2012 15:08:08 EST</pubDate>
	 <guid isPermaLink="false">news259250838</guid>
	 
</item>
<item>
     <title>Long-ignored enzyme turns out to be key to killing infectious bacteria</title>
   	 <description>New research shows that an enzyme that has long been considered relatively useless to the immune response instead has an important role in setting up immune cells to kill infection-causing bacteria.</description>
     <link>http://medicalxpress.com/news/2012-06-long-ignored-enzyme-key-infectious-bacteria.html</link>
	 <category>Immunology</category>
	 <pubDate>Mon, 11 Jun 2012 13:08:55 EST</pubDate>
	 <guid isPermaLink="false">news258638926</guid>
	 
</item>
<item>
     <title>New clinical study evaluates first drug to show improvement in subtype of autism</title>
   	 <description>In an important test of one of the first drugs to target core symptoms of autism, researchers at Mount Sinai School of Medicine are undertaking a pilot clinical trial to evaluate insulin-like growth factor (IGF-1) in children who have SHANK3 deficiency (also known as 22q13 Deletion Syndrome or Phelan-McDermid Syndrome), a known cause of autism spectrum disorder (ASD).</description>
     <link>http://medicalxpress.com/news/2012-04-clinical-drug-subtype-autism.html</link>
	 <category>Autism spectrum disorders</category>
	 <pubDate>Tue, 24 Apr 2012 14:47:17 EST</pubDate>
	 <guid isPermaLink="false">news254497462</guid>
	 
</item>
<item>
     <title>Fatty livers are in overdrive</title>
   	 <description>When our livers become loaded with fat, it isn't because they are slacking. A new study of human patients in the December Cell Metabolism shows that fatty livers actually burn more fat, not less. All that &quot;hard work&quot; may be at the root of the organ damage that comes with nonalcoholic fatty liver disease (NAFLD), a condition associated with insulin resistance that affects about one in three in the U.S. population.</description>
     <link>http://medicalxpress.com/news/2011-12-fatty-livers-overdrive.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 06 Dec 2011 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news242399349</guid>
	 
</item>
<item>
     <title>Engineered, drug-secreting blood vessels reverse anemia in mice</title>
   	 <description>Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream. In the November 17 issue of the journal Blood, they provide proof-of-concept, reversing anemia in mice with engineered vessels secreting erythropoietin (EPO).</description>
     <link>http://medicalxpress.com/news/2011-11-drug-secreting-blood-vessels-reverse-anemia.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 15 Nov 2011 16:27:32 EST</pubDate>
	 <guid isPermaLink="false">news240596839</guid>
	 
</item>


</channel>
</rss>
